 | |||||
| in | |||||
| NEWS | |||||
| Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease In the six patients with normal left ventricular ejection fraction at baseline, we observed cardiac LAMP2 protein expression and a reduction from ...
| |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
ShareThis
No comments:
Post a Comment